Search
Search

Leveraging Telemetry to Expand
Beyond the Standard Endpoints

At the 2026 Society of Toxicology Annual Meeting, emka & SCIREQ hosted a scientific session focused on leveraging Telemetry to expand beyond the standard endpoints.


William Salvail (IPS Therapeutique Inc.) presented how his team is validating the emka easyTEL+ digital telemetry implant for biopotentials and blood pressure measurement in mice, while Dr. Beth Geist and Dr. Daniel Edelberg (Kardigan) presented their initial experiences leveraging the easyTEL+ telemetry system on rats.

Download the summary